It is interesting to note that this study concluded that surface markers' ability to enrich for TPCs was influenced by the genotype of the tumor; in KRAS mutant mice, tumors containing only KRAS mutations did not exhibit tumors that Sca-1 enriched for TPCs. This evidence concerns the gene KRAS and neoplasm.